Clinical trial
Permethrin-Treated Baby Wraps for The Prevention of Malaria in Refugee Settings
NCT07903324 is registered in ClinicalTrials.gov with University of North Carolina, Chapel Hill as lead sponsor.
Follow this trial by email Email me the PDF
Summary
Not yet recruiting, started September 2027. Interventional study, 1,350 participants (estimated). Lead sponsor University of North Carolina, Chapel Hill; Uganda. Primary measure: Incidence of clinical malaria in children.
How it compares
63 similar trials: same condition (Malaria, Falciparum) and phase
Registry record
As filed in ClinicalTrials.gov.
- Title
- Permethrin-Treated Baby Wraps for The Prevention of Malaria in Refugee Settings
- Lead sponsor
- University of North Carolina, Chapel Hill
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- September 1, 2027
- Completion date
- September 1, 2030
- Enrollment
- 1,350 (estimated)
- Sites
- 1
Conditions
MeSH condition names; the registry's own terms follow.
Registry terms: malaria (plasmodium falciparum), malaria incidence
Who could take part, where it ran, who ran it
As filed in ClinicalTrials.gov.
- Sex
- All
- Minimum age
- 3 Months
- Maximum age
- 99 Years
- Healthy volunteers
- Yes
- Study type
- Interventional
- Sites
- 1
- Countries
- Uganda
- Lead sponsor
- University of North Carolina, Chapel Hill
Arms
As registered; 3 arms.
| Arm | Type | Interventions |
|---|---|---|
| Receives factory-treated permethrin lesu | Experimental | Factory-treated lesu |
Show registry wordingReceives factory-treated (0.52%) permethrin-treated wrap for 6 months | ||
| Receives soaked permethrin lesu | Experimental | Soaked lesu |
Show registry wordingReceives soaked (1%) permethrin-treated wrap for 6 months | ||
| Receives untreated lesu | Sham comparator | Untreated lesu |
Show registry wordingReceives the untreated lesu for 6 months | ||
Primary endpoints
Registered primary outcome measures; 1 primary.
| Measure | Time frame |
|---|---|
| Incidence of clinical malaria in children | From enrollment to Month 6 |
Show registry wordingAcute febrile illness defined as fever (temperature ≥38.0 Celsius) or fever reported in past 24 hours AND positive malaria rapid diagnostic test (RDT), confirmed by light microscopy (performed later), at scheduled or unscheduled study clinic visit | |
Lead sponsor's other trials
University of North Carolina, Chapel Hill, most recent start first.
+1,367 more trials
Similar trials
Same condition (Malaria, Falciparum) and phase, most recent start first.
+58 more trials See the condition page